Henry I. Miller, MS, MD, has been a research fellow at the Hoover Institution since 1994. His research focuses on public policy toward science and technology, especially pharmaceutical development and the new biotechnology. Dr. Miller is a widely respected expert on regulatory issues.
Between 1979 and 1994, prior to his position at the Hoover Institution, Dr. Miller worked at the Food and Drug Administration. There he held various positions involved with the regulation of drugs and biologics. He was the medical reviewer for the first drugs obtained from recombinant DNA-modified organisms evaluated by the FDA and was instrumental in the rapid licensing of human insulin and human growth hormone.
He has also served as special assistant to the FDA commissioner, and from 1989 to 1994 he was the founding director of the FDA's Office of Biotechnology. While a government official, Dr. Miller often represented the FDA or U.S. Government on panels and at conferences.
Dr. Miller has authored or co-authored six monographs, the most recent of which is "The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution" (Praeger Publishers, 2004), and he has published extensively in prominent medical, scientific, and public affairs journals and newspapers worldwide. He serves on the editorial boards of several journals and an adjunct scholar or fellow at several think tanks, and is the recipient of numerous prestigious awards and lectureships.